We are live on
!
Find out more
PM
Prosight Management Portfolio holdings
AUM
$610M
1-Year Est. Return
40.86%
This Fund
S&P 500
This Quarter
Est. Return
+26.89%
1 Year Est. Return
+40.86%
3 Year Est. Return
+46.17%
5 Year Est. Return
+1.2%
10 Year Est. Return
–
AUM
$201M
AUM Growth
-$11.2M
(-5.3%)
Cap. Flow
-$54.1M
Cap. Flow
% of AUM
-26.85%
Top 10 Holdings %
Top 10 Hldgs %
49.03%
Holding
61
New
17
Increased
9
Reduced
21
Closed
12
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
+$7.06M |
| 2 |
APTO
Aptose Biosciences, Inc.
APTO
|
+$5.61M |
| 3 |
CLLS
Cellectis
CLLS
|
+$4.21M |
| 4 |
Baxter International
BAX
|
+$3.7M |
| 5 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
+$3.04M |
Top Sells
| 1 |
Iovance Biotherapeutics
IOVA
|
+$11.1M |
| 2 |
Kura Oncology
KURA
|
+$11M |
| 3 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
+$10.6M |
| 4 |
United Therapeutics
UTHR
|
+$8.89M |
| 5 |
Direxion Daily Small Cap Bear 3x ETF
TZA
|
+$7.42M |
Sector Composition
| 1 | Healthcare | 92.54% |
| 2 | Technology | 4.62% |
| 3 | Energy | 0.39% |
| 4 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Pacira BioSciences
PCRX
$997M
| $2.89M | 1.43% |
+55,000
| New | +$2.3M |
|
27
Personalis
PSNL
$1.65B
| $2.45M | 1.22% |
188,750
-225,990
| -54% | -$2.51M |
|
28
Establishment Labs
ESTA
$2.67B
| $2.38M | 1.18% |
127,173
+515
| +0.4% | +$8.76K |
|
29
Immunovant
IMVT
$8.19B
| $2.33M | 1.15% |
95,500
-25,929
| -21% | -$556K |
|
30
Organogenesis Holdings
ORGO
$320M
| $2.06M | 1.02% |
535,616
-136,659
| -20% | -$493K |
|
31
Encompass Health
EHC
$10.9B
| $2.04M | 1.01% |
41,355
-17,598
| -30% | -$950K |
|
|
32
United Therapeutics
UTHR
$22.6B
| $1.81M | 0.9% |
15,000
-79,000
| -84% | -$8.89M |
|
|
TPTX
33
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $1.65M | 0.82% |
+25,602
| New | +$1.48M |
|
|
TBIO
34
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $1.6M | 0.8% |
+89,510
| New | +$1.35M |
|
35
Aurinia Pharmaceuticals
AUPH
$2.07B
| $1.5M | 0.74% |
+92,000
| New | +$1.47M |
|
36
Evolus
EOLS
$392M
| $1.49M | 0.74% |
281,541
-232,665
| -45% | -$1.07M |
|
|
TVRD
37
Tvardi Therapeutics
TVRD
$27.5M
| $1.49M | 0.74% |
+2,416
| New | +$1.33M |
|
38
Gyre Therapeutics
GYRE
$731M
| $1.46M | 0.72% |
33,073
-17,980
| -35% | -$844K |
|
39
Dianthus Therapeutics
DNTH
$5.46B
| $1.27M | 0.63% |
+10,536
| New | +$1.48M |
|
40
AMN Healthcare
AMN
$1.25B
| $1.22M | 0.6% |
26,851
-56,620
| -68% | -$2.71M |
|
41
NeoGenomics
NEO
$1.89B
| $1.2M | 0.6% |
+38,819
| New | +$1.08M |
|
|
MODV
42
DELISTED
ModivCare
MODV
| $1.18M | 0.58% |
+14,923
| New | +$1.01M |
|
|
EVFM
43
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $1.17M | 0.58% |
+27,519
| New | +$1.85M |
|
|
BEAT
44
DELISTED
BioTelemetry, Inc.
BEAT
| $1.12M | 0.56% |
+24,733
| New | +$1.11M |
|
45
Xeris Biopharma Holdings
XERS
$1.5B
| $1.12M | 0.55% |
+419,469
| New | +$1.46M |
|
|
LHCG
46
DELISTED
LHC Group LLC
LHCG
| $786K | 0.39% |
4,509
-30,400
| -87% | -$4.46M |
|
|
APEN
47
DELISTED
Apollo Endosurgery, Inc.
APEN
| $621K | 0.31% |
379,945
+42,683
| +13% | +$84.8K |
|
|
MITO
48
DELISTED
Stealth BioTherapeutics Corp. ADS
MITO
| $533K | 0.26% |
291,144
-45,023
| -13% | -$82K |
|
|
MGLN
49
DELISTED
Magellan Health Services, Inc.
MGLN
| $379K | 0.19% |
+5,200
| New | +$333K |
|
|
ONEM
50
PUT
DELISTED
1Life Healthcare
ONEM
| $291K | 0.14% |
+8,000
| New | +$225K |
|
Similar funds
PL
BFC
ACM
FFWA
SAM
CBB
AIG
IA